SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-025149
Filing Date
2014-06-27
Accepted
2014-06-27 16:55:19
Documents
1
Period of Report
2014-06-27

Document Format Files

Seq Description Document Type Size
1 ANNUAL OPTION GRANT rrd412174.html 4  
1 ANNUAL OPTION GRANT rrd412174.xml 4 4313
  Complete submission text file 0001181431-14-025149.txt   5696
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037
Business Address
Honig Peter (Reporting) CIK: 0001484780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 14946542